Microscopic Polyangiitis (MPA) Treatment Market Report

Global and Region Microscopic Polyangiitis (MPA) Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：235
  • REPORT CODE：GMM950260
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Microscopic Polyangiitis (MPA) Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Microscopic Polyangiitis (MPA) Treatmentmarket, defines the market attractiveness level of Microscopic Polyangiitis (MPA) Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Microscopic Polyangiitis (MPA) Treatment industry, describes the types of Microscopic Polyangiitis (MPA) Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Microscopic Polyangiitis (MPA) Treatment market and the development prospects and opportunities of Microscopic Polyangiitis (MPA) Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Microscopic Polyangiitis (MPA) Treatment market in Chapter 13.

    By Player:

    • Celltrion Inc

    • Teijin Pharma Ltd

    • ChemoCentryx Inc

    • TTY Biopharm Company Ltd

    • Sandoz International GmbH

    By Type:

    • Avacopan

    • Immune Globulin

    • Rituximab Biosimilar

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Microscopic Polyangiitis (MPA) Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Microscopic Polyangiitis (MPA) Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Microscopic Polyangiitis (MPA) Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Microscopic Polyangiitis (MPA) Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Microscopic Polyangiitis (MPA) Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Microscopic Polyangiitis (MPA) Treatment Consumption (2017-2022)

    • 7.2 United States Microscopic Polyangiitis (MPA) Treatment Consumption (2017-2022)

    • 7.3 Europe Microscopic Polyangiitis (MPA) Treatment Consumption (2017-2022)

    • 7.4 China Microscopic Polyangiitis (MPA) Treatment Consumption (2017-2022)

    • 7.5 Japan Microscopic Polyangiitis (MPA) Treatment Consumption (2017-2022)

    • 7.6 India Microscopic Polyangiitis (MPA) Treatment Consumption (2017-2022)

    • 7.7 South Korea Microscopic Polyangiitis (MPA) Treatment Consumption (2017-2022)

    8 Region and Country-wise Microscopic Polyangiitis (MPA) Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Microscopic Polyangiitis (MPA) Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Microscopic Polyangiitis (MPA) Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Microscopic Polyangiitis (MPA) Treatment Consumption Forecast (2022-2028)

    • 8.4 China Microscopic Polyangiitis (MPA) Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Microscopic Polyangiitis (MPA) Treatment Consumption Forecast (2022-2028)

    • 8.6 India Microscopic Polyangiitis (MPA) Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Microscopic Polyangiitis (MPA) Treatment Consumption Forecast (2022-2028)

    9 Global Microscopic Polyangiitis (MPA) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Microscopic Polyangiitis (MPA) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Avacopan Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Immune Globulin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Rituximab Biosimilar Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Microscopic Polyangiitis (MPA) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Microscopic Polyangiitis (MPA) Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Microscopic Polyangiitis (MPA) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Avacopan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Immune Globulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Rituximab Biosimilar Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Microscopic Polyangiitis (MPA) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Microscopic Polyangiitis (MPA) Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Microscopic Polyangiitis (MPA) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Microscopic Polyangiitis (MPA) Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Microscopic Polyangiitis (MPA) Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Microscopic Polyangiitis (MPA) Treatment Market Competitive Analysis

    • 14.1 Celltrion Inc

      • 14.1.1 Celltrion Inc Company Details

      • 14.1.2 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Product and Service

    • 14.2 Teijin Pharma Ltd

      • 14.2.1 Teijin Pharma Ltd Company Details

      • 14.2.2 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Product and Service

    • 14.3 ChemoCentryx Inc

      • 14.3.1 ChemoCentryx Inc Company Details

      • 14.3.2 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Product and Service

    • 14.4 TTY Biopharm Company Ltd

      • 14.4.1 TTY Biopharm Company Ltd Company Details

      • 14.4.2 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Product and Service

    • 14.5 Sandoz International GmbH

      • 14.5.1 Sandoz International GmbH Company Details

      • 14.5.2 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Microscopic Polyangiitis (MPA) Treatment

    • Figure Microscopic Polyangiitis (MPA) Treatment Picture

    • Table Global Microscopic Polyangiitis (MPA) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Microscopic Polyangiitis (MPA) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Microscopic Polyangiitis (MPA) Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Microscopic Polyangiitis (MPA) Treatment Consumption by Country (2017-2022)

    • Figure United States Microscopic Polyangiitis (MPA) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Microscopic Polyangiitis (MPA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Microscopic Polyangiitis (MPA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Microscopic Polyangiitis (MPA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Microscopic Polyangiitis (MPA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Microscopic Polyangiitis (MPA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Microscopic Polyangiitis (MPA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Microscopic Polyangiitis (MPA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Microscopic Polyangiitis (MPA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Microscopic Polyangiitis (MPA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Microscopic Polyangiitis (MPA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Microscopic Polyangiitis (MPA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Microscopic Polyangiitis (MPA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Avacopan Consumption and Growth Rate (2017-2022)

    • Figure Global Immune Globulin Consumption and Growth Rate (2017-2022)

    • Figure Global Rituximab Biosimilar Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Avacopan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immune Globulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rituximab Biosimilar Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Microscopic Polyangiitis (MPA) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Microscopic Polyangiitis (MPA) Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Celltrion Inc (Foundation Year, Company Profile and etc.)

    • Table Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Product and Service

    • Table Teijin Pharma Ltd (Foundation Year, Company Profile and etc.)

    • Table Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Product and Service

    • Table ChemoCentryx Inc (Foundation Year, Company Profile and etc.)

    • Table ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Product and Service

    • Table TTY Biopharm Company Ltd (Foundation Year, Company Profile and etc.)

    • Table TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Product and Service

    • Table Sandoz International GmbH (Foundation Year, Company Profile and etc.)

    • Table Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US